These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18855271)

  • 1. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
    Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodriguez-Lopez L; Escalante-Acosta BA
    Clin Exp Hypertens; 2008 Oct; 30(7):682-8. PubMed ID: 18855271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
    Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodríguez-Lopez L; Castro-Serna D; Escalante-Acosta BA
    Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):193-7. PubMed ID: 21737486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between circulating adhesion molecule levels and albuminuria in type-2 diabetic hypertensive patients.
    Rubio-Guerra AF; Vargas-Robles H; Lozano Nuevo JJ; Escalante-Acosta BA
    Kidney Blood Press Res; 2009; 32(2):106-9. PubMed ID: 19342863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levels of soluble adhesion molecules among normal and hypertensive type 2 diabetic patients].
    Rubio-Guerra AF; Vargas-Robles H; Medina-Santillán R; Escalante-Acosta BA
    Gac Med Mex; 2008; 144(1):11-4. PubMed ID: 18619052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension.
    Boulbou MS; Koukoulis GN; Makri ED; Petinaki EA; Gourgoulianis KI; Germenis AE
    Int J Cardiol; 2005 Jan; 98(1):39-44. PubMed ID: 15676164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
    Fernández González R; García Robles R; Rodríguez Pérez JC; Gómez Pajuelo C; Moreno Carretero E;
    Nefrologia; 2001; 21(5):456-63. PubMed ID: 11795014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing microalbuminuria in type 2 diabetes.
    Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
    N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
    Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
    Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between circulating adhesion molecule levels and albuminuria in type 2 diabetic normotensive patients.
    Rubio-Guerra AF; Vargas-Robles H; Ayala GV; Escalante-Acosta BA
    Med Sci Monit; 2007 Aug; 13(8):CR349-52. PubMed ID: 17660723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
    Fernández R; Puig JG; Rodríguez-Pérez JC; Garrido J; Redon J;
    J Hum Hypertens; 2001 Dec; 15(12):849-56. PubMed ID: 11773987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adhesion molecules in type 2 diabetes].
    Sokup A
    Przegl Lek; 2005; 62(4):234-7. PubMed ID: 16229242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes.
    Rubio-Guerra AF; Arceo-Navarro A; Vargas-Ayala G; Rodriguez-Lopez L; Lozano-Nuevo JJ; Gomez-Harper CT
    Diabetes Care; 2004 Jul; 27(7):1688-91. PubMed ID: 15220247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus.
    Rizzoni D; Muiesan ML; Porteri E; Castellano M; Salvetti M; Monteduro C; De Ciuceis C; Boari G; Valentini U; Cimino A; Sleiman I; Agabiti-Rosei E
    J Hum Hypertens; 2003 Jul; 17(7):463-70. PubMed ID: 12821953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.
    Turhan H; Saydam GS; Erbay AR; Ayaz S; Yasar AS; Aksoy Y; Basar N; Yetkin E
    Int J Cardiol; 2006 Apr; 108(2):224-30. PubMed ID: 16002164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease.
    Boulbou MS; Koukoulis GN; Vasiou KG; Petinaki EA; Gourgoulianis KI; Fezoulidis IB
    Int Angiol; 2004 Mar; 23(1):18-24. PubMed ID: 15156125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control.
    Steiner M; Reinhardt KM; Krammer B; Ernst B; Blann AD
    Thromb Haemost; 1994 Dec; 72(6):979-84. PubMed ID: 7537916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.